| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |